Results 171 to 180 of about 56,658 (237)

Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system. [PDF]

Saudi Pharm J
Alshammari TM.
europepmc   +1 more source

Empiric outpatient antibiotic prescribing patterns in the emergency department. [PDF]

Antimicrob Steward Healthc Epidemiol
Badwal A, Buffone B, San C, Leung V, Lee C.   +4 more
europepmc   +1 more source

HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to Fluoroquinolones. [PDF]

Liver Int
Nicoletti P, Lucena MI, Andrade RJ, Zafer S, Bjornsson ES, Hallberg P, Larrey D, Molokhia M, Wadelius M, Aithal GP, Daly AK.   +10 more
europepmc   +1 more source

Epidemiological burden of multidrug-resistant bacteria and carbapenemases in Northern Morocco: a one-year observational study. [PDF]

BMC Infect Dis
El Harrak K, Al Faqir I, El Ghorba EM, Amrani Souhli R, Chahid N, Arbai M, El-Hassouni M, Bousgheiri F, Najdi A, Rissoul K.   +9 more
europepmc   +1 more source

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain. [PDF]

IJTLD Open
Schiuma M, Piubello A, Saluzzo F, Cattaneo D, Salari F, Covizzi A, Rizzo A, Fama F, Ciubotariu C, Lombardi A, Antinori S, Riva A, Cirillo DM, Gori A, Torre A.   +14 more
europepmc   +1 more source

Diagnosis and Treatment of Cystitis in Dogs: An Italian Survey. [PDF]

Vet Sci
Fidanzio F, Tirelli I, Bertini S, Carrillo Heredero AM, Intorre L, Lippi I, Marchetti V, Quintavalla C, Corsini A.   +8 more
europepmc   +1 more source